Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × Doxorubicin × 30 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 10 Burkitt Lymphoma 9 Neoplasms 8 Lymphoma, Follicular 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Lymphoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasm Metastasis 4 Fallopian Tube Neoplasms 4 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell, Marginal Zone 3 Liposarcoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Biphenotypic, Acute 3 Hodgkin Disease 3 Endometrial Neoplasms 3 Sarcoma, Ewing 2 Sarcoma 2 Osteosarcoma 2 Leiomyosarcoma 2 Histiocytoma, Malignant Fibrous 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Thymoma 1

Interventions

Specimen Handling 6 Biopsy 6 decitabine and cedazuridine drug combination 2 Azacitidine 2 venetoclax 1 veliparib 1 ruxolitinib 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 iadademstat 1 fludarabine 1 fedratinib 1 axatilimab 1 Topotecan 1 Succimer 1 Pentetic Acid 1 Injections 1 Idarubicin 1 High-Energy Shock Waves 1 Granulocyte Colony-Stimulating Factor 1 Geritol 1 Edetic Acid 1 Decitabine 1 Cytarabine 1 Carboplatin 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡